To our knowledge, besides one Sq-NSCLC patient with FGFR1 amplified tumor, who achieved PR in NCT00979134 study and had no FGFR1 protein overexpression (23) there is luck of clear results for clinical significance of FGFR1 protein expression. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.